Mountain/West Coast - From Diagnosis to Decisions: Taking Charge of Your AML Care
Join us for this free, virtual, regional event designed to help you better understand your AML diagnosis and feel more confident in making treatment decisions. Dr. Brian Jonas will walk us through the basics of AML, the importance of genetic testing, and how to advocate for the best care with your healthcare team. You’ll also be introduced to local resources, support organizations, and others in your area who understand what you're going through. Join us to get informed, ask questions, and feel more equipped to take the next steps in your care.
Mary introduces the agenda for the event and featured speaker Dr. Brian Jonas
Dr. Jonas talks about AML basics and testing
Type your questions in the chat and we will answer them!
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. Brian Jonas
Dr. Brian A. Jonas is a Professor and Chief of the Division of Malignant Hematology/Cellular Therapy and Transplantation in the Department of Internal Medicine at the UC Davis School of Medicine and UC Davis Comprehensive Cancer Center (UCDCCC). Dr. Jonas is a clinician-scientist who specializes in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL), and other myeloid malignancies. Dr. Jonas leads UCDCCC clinical and translational research in AML, MDS, and ALL, with an emphasis on early drug development. He is PI on several clinical trials, including multiple investigator-initiated trials and national trials. He chairs the UCDCCC Hematological Malignancies Disease Team Committee and is Chair of the UCDCCC Data and Safety Monitoring Committee. He sits on the NCCN panels for AML, MDS, and ALL